
Enable job alerts via email!
A cancer research organization in Malaysia is seeking a Research Associate to conduct pivotal studies in cancer biology. The candidate will design experiments, analyze data, and communicate findings, contributing to the development of targeted therapies for cancers affecting the Asian population. Ideal applicants possess a Master's or Bachelor's degree and relevant experience. This position offers a chance to impact cancer research significantly.
The Translational Cancer Biology Research Unit identifies and investigates the unique and critical genetic, molecular and cellular changes underlying cancer development, particularly in cancers that disproportionately affect Asians. Our work provides insights into disease mechanisms with implications for the development of improved therapies for cancers. This includes integrating large-scale drug response data with gene dependency and multi-omics data to improve our understanding of critical genes that keep the cancer cells alive, as well as uncovering the mechanism of action of drugs with their associated biomarkers. The goal is to identify and prioritize novel targeted therapies for head and neck cancers.
The Research Associate (“RA”) will be responsible for delivering milestones of the research program. Specifically, the RA will be assisting the Head of Research Unit to conduct follow-up studies on genes identified from the CRISPR/Cas9 and high-throughput drug screens, to determine the functional impact of these genes on cell viability and immunomodulation. The RA will work on investigating the mechanism of action of any associated drug(s) as monotherapy and when in combination with other standard of care therapies, especially immunotherapy. This includes using cell and molecular biology techniques such as knock-in/knock-out experiments, cell viability assays, RT-PCR, Western blot, flow cytometry, and the use of 2D and 3d in vitro and in vivo models. Together, these experiments will enable the team to uncover the function of these genes in the context of head and neck cancers and how they affect the action of cancer drugs that could be exploited for therapeutic impact, and further extend its application for other cancer types.
We are an independent and non‑profit cancer research organisation based in Malaysia. Funded by donations and research grants, we conduct research in niche cancers often found in our Asian population.
Cancer — the big ‘C’ — continues to be a stigma, only spoken about in hushed whispers; how it’s bad karma, how much it costs, and that nothing could be done.
Confronting this stigma head on, CRM has been reversing this language of cancer, transforming the big ‘C’ to a little ‘c’, and we plan to develop tools backed by good research to ensure that we can truly fight cancer on all fronts.
We believe that we will reverse the grip of cancer in our lives. We want researchers to win the war against cancer by turning it around with new ways of prevention and cure. We want to empower the public through impactful outreach programmes, with the hopes that Malaysians will respond differently to cancer by coming forward for screenings and going through with treatments.
Our driving force is held together by these goals: